Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07364630 · ClinicalTrials.gov registry record · Phase 4
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
A Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer, sponsored by BioLab Holdings.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07364630: Recruiting Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer, sponsored by BioLab Holdings.
NCT07364630 is a Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer that is actively recruiting participants, run by BioLab Holdings. The registered enrollment target is 50 participants, below the 254-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07364630, a Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer, is actively recruiting participants, sponsored by BioLab Holdings.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is a multicenter, prospective, controlled modified multi-platform trial assessing the efficacy of human placental membrane products and standard of care in the management of nonhealing diabetic foot ulcers and venous leg ulcers.
Primary Outcome
The percentage of target ulcers achieving complete wound closure in 12 weeks.
Conditions Studied
Interventions
- OTHER Tri-Membrane Wrap™ DFU
- OTHER Membrane Wrap™ DFU
- OTHER Membrane Wrap-Lite™ DFU
- OTHER Membrane Wrap-Hydro™ DFU
- OTHER Tri-Membrane Wrap™ VLU
Study Locations (1)
Pennsylvania
- Center for Foot and Ankle Disorders - Philidelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-01-02 |
| Est. Completion | 2027-01 |
| Phase | Phase 4 |
What NCT07364630 shows while recruiting
NCT07364630 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 254-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (80% lower).
The record links to 9 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 5 interventions - of which Tri-Membrane Wrap™ DFU is the first listed.
NCT07364630 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07364630 about?
NCT07364630 is a clinical study titled "A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.". The study is a multicenter, prospective, controlled modified multi-platform trial assessing the efficacy of human placental membrane products and standard of care in the management of nonhealing diabetic foot ulcers and venous leg ulcers.
What is the current status of trial NCT07364630?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2026-01-02. Estimated completion is 2027-01.
What conditions does trial NCT07364630 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Venous Leg Ulcer, Ulcer, Venous Ulcer, Ulcer Foot.
What interventions are being tested in trial NCT07364630?
The interventions under investigation include: Tri-Membrane Wrap™ DFU (OTHER), Membrane Wrap™ DFU (OTHER), Membrane Wrap-Lite™ DFU (OTHER), Membrane Wrap-Hydro™ DFU (OTHER), Tri-Membrane Wrap™ VLU (OTHER).
Who is sponsoring clinical trial NCT07364630?
This trial is sponsored by BioLab Holdings, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07364630 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07364630's enrollment target sits among peer trials
50 49th of 67 higher than 18 of 67 other Diabetic Foot Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
RECRUITING · Phase 4
-
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)
RECRUITING · Phase 4
-
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
RECRUITING · Phase 4
-
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · Phase 4
-
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
RECRUITING · Phase 4
-
Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI